Month: March 2025

TAIZHOU, China, March 17, 2025 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (Nasdaq: SXTC) (the “Company”),  a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced that the Company received a written notification (the “Compliance Notice”) from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) dated March 13, 2025, informing the Company that it has regained compliance with the Nasdaq Listing Rule 5550(a)(2) (“Minimum Bid Price Requirement”) and the matter is closed. As previously announced, the Company received a notification letter...

Green Rain Solar, a subsidiary of The Now Corporation, partners with ChargeTronix to expand in renewable energy and EV charging Key Overview:Green Rain Solar Partners with ChargeTronix for EV Charging ExpansionGreen Rain Solar, a subsidiary of The Now Corporation (OTC: NWPN), has secured a reseller agreement with ChargeTronix to distribute state-of-the-art EV charging stations across North America, advancing sustainable energy solutions. Strategic Growth in Hospitality: EV Charging at Hilton LocationsGreen Rain Solar has identified 13 Hilton locations for EV charging installations, supporting Hilton’s sustainability initiatives while expanding its presence in the hospitality sector and urban EV infrastructure. White-Label EV Charging Solutions for BusinessesThe partnership allows Green Rain Solar to offer white-labeled EV charging stations,...

AI Power Roadmap of 3.2 kW, 4.5 kW, and 8.5 kW PSUs enable new levels of energy efficiency, reduced electricity costs, and extended lifetime. TORRANCE, Calif., March 17, 2025 (GLOBE NEWSWIRE) — Navitas Semiconductor (Nasdaq: NVTS), the only pure-play, next-generation power semiconductor company and industry leader in gallium nitride (GaN) power ICs and silicon carbide (SiC) technology, has announced that its portfolio of 3.2kW, 4.5kW, and 8.5 kW AI data center power supply unit (PSU) designs exceed the new 80 PLUS ‘Ruby’ certification, focused on the highest level of efficiency for redundant server data center PSUs.The 80 PLUS certification program assesses and certifies the energy efficiency of internal PSUs in computers and servers. The ‘Ruby’ certification was announced in January 2025 by 80 PLUS’s administrating body,...

Realignment of Development and Product Distribution Efforts Focuses on Accelerating Cash Flow Performance COLUMBIA, Md., March 17, 2025 (GLOBE NEWSWIRE) — Rekor Systems, Inc. (NASDAQ: REKR), a global leader in roadway intelligence, today provided insights into its preliminary year-end 2024 results and recent actions to improve financial performance by reducing the level of operating losses while positioning the Company for growth both domestically and internationally. Based on preliminary and unaudited financial results, full-year 2024 revenue is expected to be above $45.5 million, representing a year-over-year increase above 30% compared to 2023. Fourth-quarter 2024 revenue is projected to be above $12.5 million, reflecting growth above 12% compared to the same period last year. The following table sets forth the components of...

ST. CLOUD, Minn., March 17, 2025 (GLOBE NEWSWIRE) — (TSX: NFI, OTC: NFYEF, TSX: NFI.DB) NFI Group Inc. (NFI) a leader in propulsion agnostic bus and coach mobility solutions, subsidiary New Flyer of America Inc. (New Flyer), today announced new firm orders from the Maryland Transit Administration (the agency) for a total of 117 buses (127 equivalent units or EUs). These awards consist of:50 Xcelsior® 40-foot hybrid-electric buses (50 EUs) and 20 Xcelsior CHARGE NG™ 40-foot battery-electric buses (20 EUs) awarded in the fourth quarter of 2024. An additional 37 Xcelsior 40-foot hybrid-electric buses (37 EUs), and 10 Xcelsior CHARGE NG 60-foot battery-electric buses (20 EUs) awarded in the first quarter of 2025.The combination of orders further solidifies New Flyer’s role in delivering sustainable, high-performance transit...

Series  RIKV 25 0521 RIKV 25 0917Settlement Date  03/19/2025 03/19/2025Total Amount Allocated (MM)  8,536 21,342All Bids Awarded At (Price / Simple interest)  98.611 / 8.049 96.089 / 8.051Total Number of Bids Received  14 23Total Amount of All Bids Received (MM)  9,836 22,742Total Number of Successful Bids  12 21Number of Bids Allocated in Full  12 21Lowest Price / Highest Simple Interest Allocated  98.611 / 8.049 96.089 / 8.051Highest Price / Lowest Simple Interest Allocated  98.647 / 7.837 96.216 / 7.779Lowest Price / Highest Simple Interest Allocated in Full  98.611 / 8.049 96.089 / 8.051Weighted Average of Successful Bids (Price/Simple Interest)  98.630 / 7.937 96.144 / 7.933Best Bid (Price / Simple Interest)  98.647 / 7.837 96.216 / 7.779Worst Bid (Price / Simple Interest)  98.602 / 8.102 96.066 / 8.100Weighted...

SINGAPORE, March 17, 2025 (GLOBE NEWSWIRE) — BitFuFu Inc. (“BitFuFu” or the “Company”) (NASDAQ: FUFU), a global leader in Bitcoin mining and comprehensive mining services, today announced that it will release its full year financial results for the year ended December 31, 2024, before U.S. markets open on March 25, 2025. The Company’s management team will hold an earnings conference call at 8:00 A.M. U.S. Eastern Time on Tuesday, March 25, 2025 (8:00 P.M. Singapore Time on the same day). All participants must register in advance of the conference call using the link provided below. Upon registration, each participant will receive a confirmation email containing dial-in numbers and a unique access PIN, which will be used to join the conference call. Registration Link: https://edge.media-server.com/mmc/p/psxtq5kh Additionally, a...

MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) — OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license agreement to advance into the clinic the first oral dual agonist GLP-1/glucagon peptide as a once-daily tablet treatment for patients with obesity, metabolic and fibrotic disorders. The program combines OPKO’s proprietary long-acting oxyntomodulin analog (OPK-88006) and Entera’s proprietary N-Tab™ technology. Favorable pharmacodynamic, pharmacokinetic and bioavailability data in vivo were reported in September 2024. The companies expect to file an Investigational New Drug application with the U.S. Food and Drug Administration (FDA) later this year. Under the terms of the agreement,...